+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Brain Cancer Drugs Market Research Reports

From
From
From
From
From
From
From
From
From
Lomustine (CAS 13010-47-4) Global Market Research Report 2024 - Product Thumbnail Image

Lomustine (CAS 13010-47-4) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Everolimus (CAS 159351-69-6) Global Market Research Report 2024 - Product Thumbnail Image

Everolimus (CAS 159351-69-6) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Carmustine (CAS 154-93-8) Global Market Research Report 2024 - Product Thumbnail Image

Carmustine (CAS 154-93-8) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Brain Cancer Treatment Drugs Companies in China - Product Thumbnail Image

Brain Cancer Treatment Drugs Companies in China

  • Report
  • September 2024
  • 83 Pages
  • China
From
Brain Cancer Treatment Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Brain Cancer Treatment Drugs Industry Forecasts - China Focus

  • Report
  • September 2024
  • 102 Pages
  • China
From
Loading Indicator

The Brain Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat brain cancer. Brain cancer is a type of cancer that affects the cells of the brain and can be caused by a variety of factors, including genetics, environmental exposure, and lifestyle. Brain cancer drugs are used to treat the symptoms of brain cancer, such as headaches, seizures, and nausea, as well as to slow the progression of the disease. Brain cancer drugs are typically divided into two categories: chemotherapy and targeted therapy. Chemotherapy drugs are used to kill cancer cells, while targeted therapy drugs are designed to target specific cancer cells and stop them from growing. Both types of drugs are used in combination to treat brain cancer. Some of the major companies in the Brain Cancer Drugs market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. These companies are involved in the development and sale of drugs used to treat brain cancer, as well as in the research and development of new treatments. Show Less Read more